Skip to main content
logo
Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.465
-0.255 (-5.40%)
May 15, 2026, 11:34 AM EDT - Market open

Nuvation Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,5553,1058993314201,853
Market Cap Growth
103.43%245.48%171.69%-21.20%-77.34%6.24%
Enterprise Value
1,3272,777403.21-278.42-238.191,089
Last Close Price
4.478.962.661.511.928.50
PE Ratio
--14.93-1.26-4.31-4.00-19.32
PS Ratio
11.4949.36114.14---
PB Ratio
5.14-2.78-0.99-0.97-1.54-11.30
P/TBV Ratio
-1.41-2.74-0.78-0.96-1.53-10.26
P/FCF Ratio
--17.87-6.88-4.86-4.35-27.06
P/OCF Ratio
--17.90-6.89-4.86-4.37-27.17
EV/Sales Ratio
9.2844.1451.21---
EV/EBITDA Ratio
--13.14-0.682.801.99-11.70
EV/EBIT Ratio
--13.03-0.682.791.99-11.67
EV/FCF Ratio
--15.98-3.094.092.47-15.91
Debt / Equity Ratio
0.650.660.020.000.000.00
Debt / EBITDA Ratio
-1.41-0.96-0.01-0.04-0.04-0.03
Debt / FCF Ratio
-1.66-1.17-0.07-0.06-0.04-0.04
Net Debt / Equity Ratio
0.290.290.541.772.414.65
Net Debt / EBITDA Ratio
2.191.540.836.105.498.19
Net Debt / FCF Ratio
2.581.883.788.926.8111.13
Asset Turnover
0.240.110.01000
Inventory Turnover
0.911.63----
Quick Ratio
7.046.678.9144.0050.4145.40
Current Ratio
7.446.959.0444.1150.7045.62
Return on Equity (ROE)
-46.70%-53.18%-106.27%-12.03%-14.87%-18.07%
Return on Assets (ROA)
-24.92%-37.53%-101.99%-15.43%-16.53%-18.70%
Return on Invested Capital (ROIC)
-933.89%-4392.17%39800.30%7801.64%3905.86%3210.11%
Return on Capital Employed (ROCE)
-28.79%-42.83%-108.75%-15.76%-16.89%-19.15%
Earnings Yield
-8.88%-6.70%-79.32%-23.18%-25.00%-5.18%
FCF Yield
-7.67%-5.60%-14.53%-20.58%-22.98%-3.70%
Buyback Yield / Dilution
-15.09%-27.07%-22.79%-1.00%-9.52%-102.90%
Total Shareholder Return
-15.09%-27.07%-22.79%-1.00%-9.52%-102.90%
Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q